Epileptic encephalopathyGene: TSC2
Comment on list classification: Made this gene red, as only one reported case in PMID: 28215400, though there is more evidence in TSC1 which is in the same pathway.
22 Sep 2017, 2:55 p.m.
PMID:19175396 reported sequence alterations in the TSC1 and TSC2 genes in lesional brain tissue and blood of Focal cortical dysplasia patients are found in a similar frequency to that of a normal population. A more recent publication (PMID: 28215400) provides evidence for somatic brian mutations in TSC1 and TSC2 to be implicated in FCD2. They took 40 patients who were negative for MTOR mutations, and found candidate causative brain somatic variants in TSC1 or TSC2 in 5 patients (3 different missense variants). In vitro assays provided evidence to show that the mutations induced activation of mTOR kinase by disturbing the formation or function of the TSC1-TSC2 complex. Using in utero CRISPR-Cas9 somatic genome-editing system, a focal cortical disruption of the TSC1-TSC2 complex, encoded by Tsc1 and Tsc2 was reported to cause spontaneous behavioral seizures as well as migration defects and cytomegalic neurons, consistent with the neuropathological phenotype of individuals with FCD2. Two of the 3 variants reported were found at a low frequency in ExAC Browser (1.65x10-5 and 3.34x10-5). One missense was reported in TSC2, in one patient.
22 Sep 2017, 2:53 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Focal cortical dysplasia, type II, somatic 607341
Mode of pathogenicity
This gene has been classified as Red List (Low Evidence).
This gene has been classified as Amber List (Moderate Evidence).
TSC2 was added to Epileptic encephalopathypanel. Sources: Literature
TSC2 was created by ellenmcdonagh